If you read the regulations, there are requirements that sponsor companies must continue to meet to receive and keep BTD. Based on my research and the timing of the Syndax and Synageva financings right before announcing BTD, one of those requirements is a firm financial footing IMO. Considering PPHM's financing vehicle is the ATM, I would say they are within their rights to finance using this vehicle if the FDA has told them it's a requirement. I suspect we'll hear about it this week.